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Case Number 14
Crohn’s Disease
Franklin Abela & Anthony Pio Dimech
Reviewed by: Ms. Josephine Psaila FRCS(Edin)
Case summary:
Demographic details:
G.J., married housewife.
Referred from: home and admitted to Surgical Ward 5.
G.J, 44-year-old female known case of Crohn’s disease and depression who presented with a few hours’ 
history of severe abdominal pain and multiple episodes of vomiting faeculant matter. An inflamed terminal 
ileum and ascending colon were found at laparatomy and resection of terminal ileum and caecum (right 
hemicolectomy) was carried out.
Presenting complaint:
Few hours’ history of: Severe abdominal pain
                                     Vomiting faeculent matter
History of presenting complaint:
The pain was initially epigastric and then migrated to the periumbilical region. She reported multiple 
episodes of vomiting faeculant matter and had passed loose stools. There was also marked abdominal 
distension.
Past medical and surgical history:
Past medical history:
Crohn’s disease (diagnosed 8 years ago in 2004).
Clinical depression.
Past surgical history:
Never had surgery.
Never had anaesthesia.
Drug History: Allergic to penicillin.
Drug Dosage Frequency Type Reason
Mirtazapine 30mg nocte Noradrenergic and 
specific serotonergic 
antidepressant 
(NaSSA)
For treatment of 
depression1
Paroxetine 40mg-20mg-0 BD SSRI (selective 
serotonin reuptake 
inhibitor)
For treatment of 
depression
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Bromazepam 3mg 2-2-2 TDS Benzodiazepine For the treatment of 
anxiety
Esomeprazole 20mg once daily Proton pump inhibitor To treat symptoms 
of gastroesophageal 
reflux disease 
(GORD)
Hydroxocobalamin 1mg once daily A synthetic injectable 
form of vitamin B12
To treat low levels 
(deficiency) of 
vitamin B12
Folic acid 5mg once daily Water-soluble B 
vitamin
To treat low levels of 
folic acid and anaemia
Mesalazine 500mg 2-2-2 TDS Anti-inflammatory 
agent
To treat inflammatory 
bowel disease
Prednisolone 30mg (tailing 
dose since last 
admission)
once daily Corticosteroid To treat inflammatory 
disease
Information on type of drug and indications was obtained from BNF, 20111
Family History: 
Nil of note.
Social History: 
The patient was a non-smoker who lived with her husband and had no relevant history of recreational 
drug use/abuse.
Systemic enquiry:
• General Health: unwell, afebrile, pale and visibly in pain.
• Cardiovascular System: haemodynamically stable. Heart sounds: S1 + S2 + 0.
• Respiratory System: clear breath sounds heard bilaterally.
• Gastrointestinal System: distended abdomen, soft with tenderness in the epigastrium (which did 
                                         not radiate to the back), left iliac fossa and infraumbilical region.
• Genitourinary System: nil of note.
• Central nervous System: nil of note.
• Musculoskeletal System: no abnormality detected.
• Endocrine System: no abnormality detected.
Treatment on admission:
Intravenous infusion of Hartmann’s solution was set up to prevent dehydration from vomiting since the 
patient was unable to tolerate oral fluids.
Nasogastric tube – to empty stomach contents in an attempt to reduce the bouts of vomiting.
Urinary catheter – to monitor fluid output and detect dehydration as early as possible.
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Discussion of results of general and specific examinations:
Crohn’s disease can affect the whole gastrointestinal system. Inflammation may occur at any point in the 
bowel, from the mouth to the anus. Tenderness over the left iliac fossa and infraumbilical region may 
have been due to the inflamed bowel, but peritonitis due to perforation of the bowel should be excluded. 
Since the patient was apyrexic, peritonitis was unlikely; however one must remember that she was on 
steroids and therefore may not have pyrexia in spite of peritonitis.
Epigastric pain may follow straining due to recurrent vomiting as well as irritation of the lower oesophagus 
by gastric acid. It can also be caused by gallbladder disease, peptic ulceration and pancreatitis. However, 
the latter was unlikely because pain did not radiate to the back2. Blood tests to detect any hepatic 
involvement were taken which turned out negative.
Bowel obstruction in Crohn’s is mainly caused by strictures due to the inflamed bowel. At times, the 
inflammation itself can reduce the diameter of the lumen enough to cause obstruction3. Bowel obstruction 
is a major cause of morbidity in patients with Crohn’s disease4. They often present with faecal vomiting 
if the stricture is in the lower gastrointestinal tract, as well as marked abdominal distension.
Loose stools and diarrhoea in Crohn’s mainly originate due to malabsorption in the large intestine. It may 
or may not be bloody7. At times, it can arise from side effects of the drugs used in Crohn’s, for example 
sulfasalazine and mesalazine1.
Differential diagnosis:
• Intestinal obstruction5 
• Peritonitis
• Peptic ulceration6
• Appendicitis
• Diverticulitis
• Bowel tuberculosis
• Small bowel cancer 
• Coeliac sprue
• Lymphoma
• Behcet’s disease
• Ischemic colitis
• Ulcerative colitis
• Infectious enteritis
• Non-steroidal drug enteropathy7
Diagnostic procedures:
Laboratory exams:
Test: Blood test.
Justification for test: The reason behind doing a full blood count in Crohn’s disease is because of the
                                  predisposition towards anaemia due to iron deficiency (malabsorption), anaemia of
                                  chronic disease, blood loss from the gastrointestinal tract and drug-induced 
                                  (e.g. mesalazine). Anaemia may also be due to folate or vitamin B12 deficiency.
                                  Thus knowing the levels of these substances in blood is important8. A high white
                                  cell count may also show signs of infection.
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                                  Measurement of the erythrocyte sedimentation rate (ESR) and the C-reactive
                                  protein (CRP) is done to determine whether there is inflammation. CRP is known 
                                  as an acute phase protein. All these tests can be altered by steroids and disease-
                                  modifying drugs.
                                  Liver function tests are required whenever a patient complains of epigastric pain, 
                                  especially if there is associated vomiting. The results can confirm or exclude
                                   biliary involvement. Serum albumin tends to be low in Crohn’s disease. It was also
                                  noted in a study that pre-operative hypoalbuminaemia was one of several factors
                                      associated with early postoperative complications in inflammatory bowel diseases9.
                                  Thus, its measurement is important. Liver function tests help to exclude any liver 
                                  pathology which can be a cause of low albumin.
                                  The reason for measuring serum magnesium levels is because of the tendency 
                                  towards malabsorption of the mineral. This may cause additional problems that
                                  need to be dealt with separately, including functional hypoparathyroidism, by 
                                  reducing the synthesis of parathyroid hormone (PTH). Low PTH can affect 
                                  adversely the kidneys and the skeleton10.
Results: Hb: 9.35g/dL (11.5-16)
              MCV: 90.3fL (79-96)
              Platelets: 280 x 109/L (150-400)
              Reticulocytes: 48.2 x 109/L (20-130)
              WBC: 4.2 x 109/L (3.5-11)
              Neutrophils Abs (Absolute Value): 8.64 x 109/L (2.5-7.5)
              Ferritin (serum): 116ng/mL (15-200)
              Vitamin B12: >738pmol/L (200-900)16
              Folate (serum): >54.4nmol/L (7-30)17
              ESR: 81mm/hr (30)
              CRP: 78mg/L (<0.8)
              Alkaline phosphatase (serum): 33U/l (30-150)
              Alanine aminotransferase (serum): 6U/l (5-35)
              Gamma glutamyl transferase (Abs): 14U/L (5-36)
              Total protein (serum): 53.1g/L (60-80)
              Albumin (serum): 32.1g/l (35-50)
              Globulin: 21.4g/l
              Magnesium (serum/plasma): 0.83mmol/l (0.75-1.2)
Conclusion: Haemoglobin levels were slightly lower than the normal range for a female. However, all
                    other blood cell parameters, as well as ferritin, vitamin B12 and folate, were normal. The
                    cause may be anaemia of chronic disease11. The ESR and CRP were high, indicating an
                    inflammatory process. Liver function was normal and there was no indication of biliary
                    pathology. A low serum protein and albumin level is a common finding in long-standing 
                    cases of Crohn’s disease, mostly due to malabsorption of nutrients from the intestine. 
                    Another rare cause is protein-losing enteropathy, which is a severe complication of Crohn’s
                        disease. It is a diagnosis of exclusion, done after eliminating malnutrition and liver or kidney 
                    failure. The pathogensis of protein-losing enteropathy implies excessive leakage of protein 
                    through the injured intestinal mucosa12.
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Instrumental exams:
Test: Chest X-ray
Justification for test: Patient was tachypnoeic.
Result: Poor respiratory effort. No obvious pulmonary lesion is seen. There was cardiomegaly and lung  
            congestion.
Conclusion: This finding had to be taken care of separately. Medications and procedures that could 
                     worsen chest signs had to be avoided.
Test: Abdominal X-ray 
Justification for test: This non-invasive test is often done to evaluate pathology in the small intestine and
                                  colon. Its importance in Crohn’s is to detect the presence of ulceration, strictures, 
                                  cobblestoning, string signs (narrow lumen), fissures and loss of haustrations7.
Result: The contrast coating of the oesophagus, stomach and duodenal bulb showed no stricture, mass
             or wall abnormality. There was no hiatus hernia. There was a stricture of a long segment of the
             terminal ileum, in keeping with Crohn’s disease. Faecal loading was visible. A slightly widened
             loop of the small bowel was noted in the left mesogastric region.
Conclusion: The strictures visible on barium follow-through were causing the obstruction, explaining the 
                    faecal vomiting and abdominal distension. 
              
                                   Figure 1                                                                      Figure 2
Figures 1,2: Barium Enema
Test: CT abdomen and pelvis
Justification for test: To exclude bowel obstruction and examine the cause of abdominal distension.
Result: Ascites and free fluid in pelvis were noted. Several sections of the small bowel showed contrast-
            enhancing oedematous walls which also involved the terminal part of the ileum. Some small 
            bowel loops (particularly in the lower abdomen) also showed distension. A radial hyper-
            dense fluid collection containing small air bubbles was seen near the terminal ileum. This might
            have possibly been a sign of incipient abscess formation. The colon was collapsed, the intestines
            in the left abdominal part were moderately distended and fluid filled. No lymphadenopathy was 
            noted. No free gas was identified. 
Conclusion: These findings were compatible with Crohn’s disease of the small bowel complicated by         
                    abscess formation and bowel obstruction.
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Test: Colonoscopy
Justification for test: Direct vision of the large bowel and terminal ileal mucosa, with the possibility of 
                                  taking biopsies7.
Result: Oedematous colonic mucosa. There was severe inflammation of a large segment of the terminal 
             ileum, caecum and ascending colon up to the hepatic flexure.
Conclusion: These findings match Crohn’s disease of the terminal ileum with extension to the proximal 
                     colon. 
Figure 3: Colonscopy
Therapy:
Drug therapy:
Drug Dose Frequency Type Reason
Metoclopramide 10mg IV TDS Dopamine receptor 
antagonist
To reduce the nausea and 
vomiting
Rantidine 50mg IVI 6-8 hourly H2-receptor antagonist To inhibit stomach acid 
production
Paracetamol 1g IVI 4-6 hourly Non-opioid analgesic Pain relief
Ciprofloxacin 400mg IV 8-12 hourly Quinolone antibiotic Prophylaxis against possible 
gastrointestinal infection 
(Gram negative and Gram 
positive)
Metronidazole 500mg 8 hourly Antibiotic Prophylaxis against 
anaerobic organisms and 
protozoa which can cause 
gastroenteritis
Information on type of drug and indications was obtained from BNF, 20111
Surgical therapy:
Pre-operative: The patient was kept nil by mouth in hospital. She was admitted for surgery as soon as all 
the investigations were carried out.
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Operation: The surgical site was disinfected and a median laparotomy incision was made. On gross 
examination, an inflamed terminal ileum, was identified. A section of colon distal to the ileocaecal valve 
was collapsed.
The right part of the colon and caecum were mobilised. The mesentery was divided to demarcate the 
dissection margins. Resection of terminal ileum and caecum with primary bowel anastomosis was carried 
out. Bowel specimens were sent for histology. The anastomosis was hand sewn using polydioxanone 
(PDS) absorbable sutures. Haemostasis was confirmed before closing. Lavage of the area was necessary. 
A Nelaton drain was inserted and secured via a nylon suture. The skin was closed with metal staples.
Post-operative period: The following instructions were given to the nursing staff in the post-operative 
period:
• Keep nil by mouth with nasogastric tube in situ
• IV fluids
• Analgesia : Paracetamol 1g IV 6 hourly , Pethidine 75mg IM 6 hourly
• DVT prophylaxis: Enoxaparin sodium 40mg SC daily and stockings
• Antibiotics: Ciprofloxacin 250mg IV
• Oxygen must also be given to the patient
On examination, the patient was stable, afebrile and not in pain. Parameters were stable (Sp O2 was 99% 
on air, blood pressure 110/80mmHg).
Diagnosis: 
The formal diagnosis in this case was that of Crohn’s disease with involvement of the terminal ileum, 
caecum and ascending colon.
Crohn’s disease is one of the two forms of chronic inflammatory bowel diseases, the other being ulcerative 
colitis. Crohn’s is relatively common in Western Europe, compared to the rest of the world and its 
incidence has increased over the past half century. Onset of the disease is early in life (at approximately 
20 years of age) with little preference between the two sexes. The aetiology of the disease is unknown, 
but there is a familial tendency towards inflammatory bowel disease in general, making scientists believe 
that it must be polygenic and genetically heterogenous. The genes involved in Crohn’s include NOD2 
and CARD15, but this remains an active area of research5.
Another, hypothesis suggests that the activation of Crohn’s disease is caused by a rapid and severe 
immunological stimulus in the bowel, such as severe gastroenteritis. The effect of this is a rapid activation 
of resting macrophages with the release of many cytokines, including interleukin-1 (IL-1). Interleukins 
bind to cellular receptors and promote an inflammatory reaction in the bowel, with all its consequences 
of tissue damage. Genetic and environmental predisposition towards the exaggerated activation of the 
immune system plays a very important role in the pathophysiology of Crohn’s. Furthermore, tobacco 
smoking predisposes to Crohn’s, but somehow exhibits a degree of protection against ulcerative colitis7.
Crohn’s disease affects any part of the gastrointestinal tract sparing some areas in between. Thus the 
disease is patchy, forming skip lesions, unlike ulcerative colitis. The following table shows the relative 
incidence of Crohn’s in different areas of the bowel:
Area of bowel Incidence Rate
Small intestine (mainly terminal ileum) 50%
Large intestine 20%
Both large and small intestine 30%
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The mouth, oesophagus, stomach and duodenum are also occasionally involved. The disease can also 
affect the perianal area, with or without influencing the large bowel5.
In Crohn’s disease, the inflammation of the bowel is transmural, i.e. involving the whole thickness of the 
bowel wall. The consequences of this include obstruction, fistulation and perforation. Several interspersed 
fissured ulcers which extend deep into the muscle layer are common, producing a cobblestone appearance. 
Granulomas (often non-caseating) are also present. They contain multinucleate giant cells. Fibrosis may 
follow prolonged inflammation, producing bowel strictures which can lead to obstruction5.
The effects of mucosal inflammation are varied. If the colon is involved, the patient may pass diarrhoea 
streaked with blood. In small bowel involvement, partial obstruction may occur, which causes colicky 
abdominal pain. Diarrhoea and malabsorption may predispose to protein-calorie malnutrition, anaemia 
(reduced iron and folate absorption) and failure to thrive (in children). If the terminal ileum is involved, 
the patient may suffer from vitamin B12 malabsorption, and if bile salts are not reabsorbed in the ileum, 
they can irritate the colon, causing more diarrhoea. In addition, lack of bile salts in the circulation 
predisposes to gallstones5.
Figure 4: General overview of Crohn’s Disease 
Transmural inflammation in Crohn’s may cause peritonitis, with severe, localised pain. In the terminal 
ileum, it may mimic appendicitis. Rarely, toxic megacolon may ensue. If the serosa is breached, adhesions 
may form to adjacent organs. However, these are rarely symptomatic. Bowel perforation may be free 
(with contents spilling out in the abdominal cavity) or contained (forming localised abscesses). Fistulae 
between the bowel and nearby hollow viscera may form. Some examples and clinical manifestations of 
these fistulae are listed in the table below5.
Type of fistula Structures involved Clinical features
Gastro-colic Colon and stomach Faecal vomiting
Ileo-rectal Ileum and rectum Exacerbation of diarrhoea
Entero-vesical Bowel and bladder Recurrent UTIs and pneumaturia
Entero-vaginal Bowel and vagina Passage of faeces through vagina
Entero-cutaneous Bowel and skin Passage of soft stools through skin opening
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Perianal involvement can occur in patients with Crohn’s disease, especially if there is small bowel 
involvement5. This can manifest itself as multiple abscesses, piles, hypertrophied skin tags, anal fissures, 
numerous fistulae between the rectum and perianal skin (pepper-pot perineum), and perineal scarring7.
Extraintestinal manifestations of Crohn’s disease may be severe and correlate with the intestinal activity 
of the condition. The joints (e.g. ankylosing spondylitis, sacroilitis), skin (e.g. erythema nodosum, 
pyoderma gangrenosum), eyes (e.g. uveitis, episcleritis), and hepatobiliary system (primary sclerosing 
cholangitis) may be implicated7.
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Fact Box 14:
Title: Crohn’s Disease
Description: Crohn’s is a chronic inflammatory bowel disorder of unknown aetiology which can affect 
the whole gastrointestinal system (from mouth to anus) and is typified by asymmetric, focal, transmural 
inflammation and sometimes granuloma formation in the bowel wall. Signs of extraintestinal manifestation 
can be marked. The life-long disease is punctuated by periods of exacerbation and remission15. Genetic 
and environmental contributors, as well as immunological factors are implicated in the pathogenesis and 
severity of Crohn’s disease.
Risk factors:
• Genetic factors (family history)
• Immune system
• Infection (mycobacteria, paramyxovirus, cytomegalovirus)7,13
• Diet (high intake of meat, fats and polyunsaturated fatty acids)14
• Smoking
• Perhaps other risk factors not yet identified
Histological features of bowel wall: 
• Transmural inflammation of bowel wall
• Thickened, oedematous, fibrotic submucosa
• Lymphoid aggregates (may extend deep to the muscularis propria)
• Non-caesating granulomas (not always present)7
Clinical features:7 
Gastrointestinal involvement:
• Nausea
• Vomiting
• Dysphagia
• Odynophagia
• Aphthous ulcers over the hard palate
• Postprandial fullness
• Abdominal pain
• Weight loss
• Anorexia
• Abdominal mass 
• Diarrhoea (may or may not be bloody) 
Extraintestinal involvement: 
• Fever
• Uveitis
• Episcleritis
• Erythema nodosum
• Pyoderma gangrenosum
• Ankylosing spondylitis
• Sacroiliitis
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• Seronegative polyarteritis
• Primary sclerosing cholangitis
Complications:5 
• Strictures
• Fistulae (intestinal, anal)
• Anal and perianal lesions
• Haemorrhage
• Intestinal obstruction
• Intestinal perforation
• Toxic megacolon (very rare)
Treatment:15  
• 5-aminosalicylic acid compounds e.g. mesalazine, sulfasalazine (modified for local release)
• Corticosteroids e.g. prednisolone and budesonide (local or systemic)
• Immunomodulators e.g. azathioprine, 6-mercaptopurine, methotrexate, infliximab
• Supportive treatment: antidiarrhoeal drugs, antispasmodics, dietary modification, vitamin and 
mineral supplements
• Surgery 
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